Academic Journal

Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.

Bibliographic Details
Title: Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.
Authors: Gulsuner S; Department of Medicine and Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA., Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, Braff DL, King MC, McClellan JM
Source: Cell [Cell] 2013 Aug 01; Vol. 154 (3), pp. 518-29.
Abstract: Genes disrupted in schizophrenia may be revealed by de novo mutations in affected persons from otherwise healthy families. Furthermore, during normal brain development, genes are expressed in patterns specific to developmental stage and neuroanatomical structure. We identified de novo mutations in persons with schizophrenia and then mapped the responsible genes onto transcriptome profiles of normal human brain tissues from age 13 weeks gestation to adulthood. In the dorsolateral and ventrolateral prefrontal cortex during fetal development, genes harboring damaging de novo mutations in schizophrenia formed a network significantly enriched for transcriptional coexpression and protein interaction. The 50 genes in the network function in neuronal migration, synaptic transmission, signaling, transcriptional regulation, and transport. These results suggest that disruptions of fetal prefrontal cortical neurogenesis are critical to the pathophysiology of schizophrenia. These results also support the feasibility of integrating genomic and transcriptome analyses to map critical neurodevelopmental processes in time and space in the brain.
(Copyright © 2013 Elsevier Inc. All rights reserved.)
Corporate Authors: Consortium on the Genetics of Schizophrenia (COGS), PAARTNERS Study Group
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Language: English
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Imprint Name(s): Publication: Cambridge, Ma : Cell Press
Original Publication: Cambridge, MIT Press.
MeSH Terms: Gene Regulatory Networks* , Mutation* , Protein Interaction Maps*, Prefrontal Cortex/*embryology , Schizophrenia/*genetics , Schizophrenia/*metabolism, Brain/embryology ; Brain/growth & development ; Brain/metabolism ; DNA Mutational Analysis ; Databases, Genetic ; Female ; Humans ; Male ; Neurogenesis ; Prefrontal Cortex/growth & development ; Prefrontal Cortex/metabolism ; Schizophrenia/physiopathology ; Transcription, Genetic ; Transcriptome
References: Nat Neurosci. 2012 Dec;15(12):1723-8. (PMID: 23143521)
Curr Top Behav Neurosci. 2010;4:373-90. (PMID: 21312407)
Nature. 2008 Oct 16;455(7215):912-8. (PMID: 18923513)
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14681-6. (PMID: 22908286)
Neuroendocrinology. 2007;85(4):257-66. (PMID: 17551263)
N Engl J Med. 2012 Oct 4;367(14):1321-31. (PMID: 22970919)
Eur J Pharmacol. 2010 Jan 25;626(2-3):123-30. (PMID: 19782679)
Nat Protoc. 2009;4(7):1073-81. (PMID: 19561590)
Nature. 2011 Mar 24;471(7339):499-503. (PMID: 21346763)
Nat Rev Neurosci. 2009 Oct;10(10):724-35. (PMID: 19763105)
Nature. 2012 Apr 04;485(7397):246-50. (PMID: 22495309)
Cell. 2010 Apr 16;141(2):210-7. (PMID: 20403315)
Nature. 2008 Sep 11;455(7210):237-41. (PMID: 18668038)
Bioinformatics. 2011 Feb 1;27(3):431-2. (PMID: 21149340)
Epigenetics. 2007 Jan-Mar;2(1):29-36. (PMID: 17965595)
Nature. 2012 Apr 04;485(7397):242-5. (PMID: 22495311)
Nature. 1998 Jun 4;393(6684):440-2. (PMID: 9623998)
J Neurosci. 2009 Sep 23;29(38):11794-806. (PMID: 19776266)
J Neurosci. 1999 Mar 15;19(6):1895-911. (PMID: 10066243)
Arch Gen Psychiatry. 1987 Jul;44(7):660-9. (PMID: 3606332)
Nature. 2011 Oct 26;478(7370):483-9. (PMID: 22031440)
Neuron. 2012 Aug 23;75(4):601-17. (PMID: 22920253)
J Neurosci. 2006 Mar 22;26(12):3102-8. (PMID: 16554461)
Nat Rev Neurosci. 2012 Jan 18;13(2):107-20. (PMID: 22251963)
J Neurosci. 2012 Sep 5;32(36):12589-602. (PMID: 22956848)
Nat Rev Genet. 2004 Feb;5(2):101-13. (PMID: 14735121)
Neuron. 2012 Sep 20;75(6):963-80. (PMID: 22998866)
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8174-9. (PMID: 15148381)
Nat Genet. 2011 Aug 07;43(9):864-8. (PMID: 21822266)
Arch Immunol Ther Exp (Warsz). 1995;43(2):117-21. (PMID: 8744726)
Nat Neurosci. 2007 Aug;10(8):963-9. (PMID: 17618280)
Science. 2008 Apr 25;320(5875):539-43. (PMID: 18369103)
Nat Genet. 2012 Dec;44(12):1365-9. (PMID: 23042115)
Neuropharmacology. 2012 Mar;62(3):1413-21. (PMID: 21110986)
Nat Genet. 2008 Jul;40(7):880-5. (PMID: 18511947)
Nature. 2012 Sep 20;489(7416):391-399. (PMID: 22996553)
Cell. 2011 Mar 18;144(6):986-98. (PMID: 21414488)
Nature. 2011 May 25;474(7351):380-4. (PMID: 21614001)
Curr Top Med Chem. 2012;12(21):2357-74. (PMID: 23279176)
Mol Cell Neurosci. 2007 Jul;35(3):409-23. (PMID: 17493827)
Neurosci Biobehav Rev. 2012 Apr;36(4):1342-56. (PMID: 22244985)
Genome Res. 2005 Jul;15(7):901-13. (PMID: 15965027)
Neuron. 1999 Feb;22(2):277-89. (PMID: 10069334)
Genome Res. 2012 Aug;22(8):1525-32. (PMID: 22585873)
Nature. 2012 Aug 23;488(7412):471-5. (PMID: 22914163)
Science. 2010 Mar 26;327(5973):1580-1. (PMID: 20339051)
Science. 1974 Sep 6;185(4154):862-4. (PMID: 4843792)
J Physiol. 2002 Apr 1;540(Pt 1):3-14. (PMID: 11927664)
Mol Psychiatry. 2012 Feb;17(2):142-53. (PMID: 22083728)
Am J Hum Genet. 2010 Jul 9;87(1):90-4. (PMID: 20602914)
Nat Methods. 2010 Apr;7(4):248-9. (PMID: 20354512)
Nature. 2007 Nov 15;450(7168):415-9. (PMID: 17928865)
Neuroscience. 2003;117(2):321-35. (PMID: 12614673)
Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17186-93. (PMID: 23045653)
PLoS One. 2012;7(8):e44017. (PMID: 22952857)
Hippocampus. 2012 May;22(5):1027-39. (PMID: 22431402)
Neuron. 2012 Apr 26;74(2):285-99. (PMID: 22542183)
Science. 2012 Dec 21;338(6114):1619-22. (PMID: 23160955)
Nature. 2008 Sep 11;455(7210):232-6. (PMID: 18668039)
Nat Genet. 2011 Jul 10;43(9):860-3. (PMID: 21743468)
Schizophr Bull. 2013 Jul;39(4):848-56. (PMID: 22532702)
Nature. 2011 May 12;473(7346):221-5. (PMID: 21490598)
Nature. 2012 Apr 04;485(7397):237-41. (PMID: 22495306)
Genome Biol. 2008;9 Suppl 1:S4. (PMID: 18613948)
Neuropsychopharmacology. 2010 Jan;35(1):258-77. (PMID: 19693005)
Science. 2007 Apr 20;316(5823):445-9. (PMID: 17363630)
Grant Information: R03TW008696 United States TW FIC NIH HHS; R01MH083989 United States MH NIMH NIH HHS; R01 MH083849 United States MH NIMH NIH HHS; R01 MH083989 United States MH NIMH NIH HHS; R01MH083849 United States MH NIMH NIH HHS; R01MH084071 United States MH NIMH NIH HHS; R03 TW008696 United States TW FIC NIH HHS; R01MH083756 United States MH NIMH NIH HHS; R01 MH083756 United States MH NIMH NIH HHS; R01 MH086135 United States MH NIMH NIH HHS; R01 MH084071 United States MH NIMH NIH HHS; U01 MH096844 United States MH NIMH NIH HHS; R01 MH093533 United States MH NIMH NIH HHS; R01 CA157744 United States CA NCI NIH HHS; T32 GM007266 United States GM NIGMS NIH HHS
Contributed Indexing: Investigator: D Braff; KS Cadenhead; ME Calkins; DJ Dobie; R Freedman; M Green; T Greenwood; RE Gur; RC Gur; L Lazzeroni; G Light; K Nuechterlein; A Olincy; A Radant; A Ray; N Schork; LJ Seidman; L Siever; J Silverman; WS Stone; C Sugar; N Swerdlow; D Tsuang; M Tsuang; B Turetsky; T Aduroja; T Allen; LD Bradford; ME Calkins; B Devlin; NB Edwards; R Ganguli; RC Go; RE Gur; RC Gur; J Kwentus; AC Lahti; P Lyons; K Mathos; R May; S McLeod-Bryant; JP McEvoy; L Montgomery-Barefield; VL Nimgaonkar; J O'Jile; A Santos; RM Savage; CL Swanson; W Wilson
Entry Date(s): Date Created: 20130806 Date Completed: 20131028 Latest Revision: 20220316
Update Code: 20240513
PubMed Central ID: PMC3894107
DOI: 10.1016/j.cell.2013.06.049
PMID: 23911319
ISSN: 1097-4172
DOI: 10.1016/j.cell.2013.06.049
Database: MEDLINE